Literature DB >> 31432717

Treatment strategies and risk of central nervous system recurrence in high-grade B-cell and Burkitt lymphoma.

Dominic P Decker1,2, Pamela C Egan1,2,3, Adam S Zayac1,2,3, Diana O Treaba1,4, Adam J Olszewski1,2,3.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31432717      PMCID： PMC6944747          DOI： 10.1080/10428194.2019.1654097

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  13 in total

1.  Secondary diffuse large B-cell lymphoma of the central nervous system: the need for better predictors.

Authors:  Mark Roschewski; Kieron Dunleavy
Journal:  Leuk Lymphoma       Date:  2015-06

2.  Treatment of initial parenchymal central nervous system involvement in systemic aggressive B-cell lymphoma.

Authors:  Marcel Nijland; Anne Jansen; Jeanette K Doorduijn; Roelien H Enting; Jacoline E C Bromberg; Hanneke C Kluin-Nelemans
Journal:  Leuk Lymphoma       Date:  2017-02-06

3.  Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia.

Authors:  Deborah A Thomas; Stefan Faderl; Susan O'Brien; Carlos Bueso-Ramos; Jorge Cortes; Guillermo Garcia-Manero; Francis J Giles; Srdan Verstovsek; William G Wierda; Sherry A Pierce; Jianqin Shan; Mark Brandt; Fredrick B Hagemeister; Michael J Keating; Fernando Cabanillas; Hagop Kantarjian
Journal:  Cancer       Date:  2006-04-01       Impact factor: 6.860

4.  Outcomes of Patients With Double-Hit Lymphoma Who Achieve First Complete Remission.

Authors:  Daniel J Landsburg; Marissa K Falkiewicz; Joseph Maly; Kristie A Blum; Christina Howlett; Tatyana Feldman; Anthony R Mato; Brian T Hill; Shaoying Li; L Jeffrey Medeiros; Pallawi Torka; Francisco Hernandez-Ilizaliturri; Nishitha M Reddy; Arun Singavi; Timothy S Fenske; Julio C Chavez; Jason B Kaplan; Amir Behdad; Adam M Petrich; Martin A Bast; Julie M Vose; Adam J Olszewski; Cristiana Costa; Frederick Lansigan; James N Gerson; Stefan K Barta; Oscar Calzada; Jonathon B Cohen; Jennifer K Lue; Jennifer E Amengual; Xavier Rivera; Daniel O Persky; David J Peace; Sunita Nathan; Ryan D Cassaday
Journal:  J Clin Oncol       Date:  2017-05-05       Impact factor: 44.544

5.  Double-Hit Gene Expression Signature Defines a Distinct Subgroup of Germinal Center B-Cell-Like Diffuse Large B-Cell Lymphoma.

Authors:  Daisuke Ennishi; Aixiang Jiang; Merrill Boyle; Brett Collinge; Bruno M Grande; Susana Ben-Neriah; Christopher Rushton; Jeffrey Tang; Nicole Thomas; Graham W Slack; Pedro Farinha; Katsuyoshi Takata; Tomoko Miyata-Takata; Jeffrey Craig; Anja Mottok; Barbara Meissner; Saeed Saberi; Ali Bashashati; Diego Villa; Kerry J Savage; Laurie H Sehn; Robert Kridel; Andrew J Mungall; Marco A Marra; Sohrab P Shah; Christian Steidl; Joseph M Connors; Randy D Gascoyne; Ryan D Morin; David W Scott
Journal:  J Clin Oncol       Date:  2018-12-03       Impact factor: 44.544

6.  B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and burkitt lymphoma: study of 39 cases.

Authors:  Anamarija M Perry; David Crockett; Bhavana J Dave; Pamela Althof; Lisa Winkler; Lynette M Smith; Patricia Aoun; Wing C Chan; Kai Fu; Timothy C Greiner; Phillip Bierman; Robert Gregory Bociek; Julie M Vose; James O Armitage; Dennis D Weisenburger
Journal:  Br J Haematol       Date:  2013-04-18       Impact factor: 6.998

7.  Low-intensity therapy in adults with Burkitt's lymphoma.

Authors:  Kieron Dunleavy; Stefania Pittaluga; Margaret Shovlin; Seth M Steinberg; Diane Cole; Cliona Grant; Brigitte Widemann; Louis M Staudt; Elaine S Jaffe; Richard F Little; Wyndham H Wilson
Journal:  N Engl J Med       Date:  2013-11-14       Impact factor: 91.245

Review 8.  Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System Recurrence.

Authors:  Thomas A Ollila; Adam J Olszewski
Journal:  Curr Treat Options Oncol       Date:  2018-06-21

9.  CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP.

Authors:  Norbert Schmitz; Samira Zeynalova; Maike Nickelsen; Roopesh Kansara; Diego Villa; Laurie H Sehn; Bertram Glass; David W Scott; Randy D Gascoyne; Joseph M Connors; Marita Ziepert; Michael Pfreundschuh; Markus Loeffler; Kerry J Savage
Journal:  J Clin Oncol       Date:  2016-07-05       Impact factor: 44.544

10.  Modified magrath regimens for adults with Burkitt and Burkitt-like lymphomas: preserved efficacy with decreased toxicity.

Authors:  A Lacasce; O Howard; S Lib; D Fisher; A Weng; D Neuberg; M Shipp
Journal:  Leuk Lymphoma       Date:  2004-04
View more
  8 in total

Review 1.  Burkitt lymphoma: bridging the gap between advances in molecular biology and therapy.

Authors:  Adam S Zayac; Adam J Olszewski
Journal:  Leuk Lymphoma       Date:  2020-04-07

2.  Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers.

Authors:  Andrew M Evens; Alexey Danilov; Deepa Jagadeesh; Amy Sperling; Seo-Hyun Kim; Ryan Vaca; Catherine Wei; Daniel Rector; Suchitra Sundaram; Nishitha Reddy; Yong Lin; Umar Farooq; Christopher D'Angelo; David A Bond; Stephanie Berg; Michael C Churnetski; Amandeep Godara; Nadia Khan; Yun Kyong Choi; Maryam Yazdy; Emma Rabinovich; Gaurav Varma; Reem Karmali; Agrima Mian; Malvi Savani; Madelyn Burkart; Peter Martin; Albert Ren; Ayushi Chauhan; Catherine Diefenbach; Allandria Straker-Edwards; Andreas K Klein; Kristie A Blum; Kirsten Marie Boughan; Scott E Smith; Brad M Haverkos; Victor M Orellana-Noia; Vaishalee P Kenkre; Adam Zayac; Jeremy Ramdial; Seth M Maliske; Narendranath Epperla; Parameswaran Venugopal; Tatyana A Feldman; Stephen D Smith; Andrzej Stadnik; Kevin A David; Seema Naik; Izidore S Lossos; Matthew A Lunning; Paolo Caimi; Manali Kamdar; Neil Palmisiano; Veronika Bachanova; Craig A Portell; Tycel Phillips; Adam J Olszewski; Juan Pablo Alderuccio
Journal:  Blood       Date:  2021-01-21       Impact factor: 22.113

3.  Outcomes of Burkitt lymphoma with central nervous system involvement: evidence from a large multicenter cohort study.

Authors:  Adam S Zayac; Andrew M Evens; Alexey Danilov; Stephen D Smith; Deepa Jagadeesh; Lori A Leslie; Catherine Wei; Seo-Hyun Kim; Seema Naik; Suchitra Sundaram; Nishitha Reddy; Umar Farooq; Vaishalee P Kenkre; Narendranath Epperla; Kristie A Blum; Nadia Khan; Daulath Singh; Juan P Alderuccio; Amandeep Godara; Maryam Sarraf Yazdy; Catherine Diefenbach; Emma Rabinovich; Gaurav Varma; Reem Karmali; Yusra Shao; Asaad Trabolsi; Madelyn Burkart; Peter Martin; Sarah Stettner; Ayushi Chauhan; Yun Kyong Choi; Allandria Straker-Edwards; Andreas Klein; Michael C Churnetski; Kirsten M Boughan; Stephanie Berg; Bradley M Haverkos; Victor M Orellana-Noia; Christopher D'Angelo; David A Bond; Seth M Maliske; Ryan Vaca; Gabriella Magarelli; Amy Sperling; Max J Gordon; Kevin A David; Malvi Savani; Paolo Caimi; Manali Kamdar; Matthew A Lunning; Neil Palmisiano; Parameswaran Venugopal; Craig A Portell; Veronika Bachanova; Tycel Phillips; Izidore S Lossos; Adam J Olszewski
Journal:  Haematologica       Date:  2021-07-01       Impact factor: 9.941

Review 4.  Challenges and Opportunities in the Management of Diffuse Large B-Cell Lymphoma in Older Patients.

Authors:  Mengyang Di; Scott F Huntington; Adam J Olszewski
Journal:  Oncologist       Date:  2020-12-09       Impact factor: 5.837

5.  Detection of clonotypic DNA in the cerebrospinal fluid as a marker of central nervous system invasion in lymphoma.

Authors:  Adam J Olszewski; Anna D Chorzalska; Max Petersen; Thomas A Ollila; Adam Zayac; Habibe Kurt; Diana O Treaba; John L Reagan; Andrew Hsu; Pamela C Egan; James Butera; Rabin Niroula; John Vatkevich; Jordan Robison; Ilyas Sahin; Allison P Jacob; Chelsea D Mullins; Patrycja M Dubielecka
Journal:  Blood Adv       Date:  2021-12-28

6.  Long-term outcome of hyper-CVAD-R for Burkitt leukemia/lymphoma and high-grade B-cell lymphoma: focus on CNS relapse.

Authors:  Bachar Samra; Joseph D Khoury; Kiyomi Morita; Farhad Ravandi; Guillaume Richard-Carpentier; Nicholas J Short; Siba El Hussein; Philip Thompson; Nitin Jain; Hagop Kantarjian; Elias Jabbour
Journal:  Blood Adv       Date:  2021-10-26

7.  Outcomes of patients with diffuse large B-cell and high-grade B-cell lymphomas with synchronous CNS and systemic involvement at diagnosis treated with high-dose methotrexate and R-CHOP: a single-center retrospective study.

Authors:  Megan Fleming; Ying Huang; Emily Dotson; David A Bond; John Reneau; Narendranath Epperla; Lapo Alinari; Jonathan Brammer; Beth Christian; Robert A Baiocchi; Kami Maddocks; Yazeed Sawalha
Journal:  Ther Adv Hematol       Date:  2022-07-23

8.  Genomic subtypes may predict the risk of central nervous system recurrence in diffuse large B-cell lymphoma.

Authors:  Thomas A Ollila; Habibe Kurt; Jozal Waroich; John Vatkevich; Ashlee Sturtevant; Nimesh R Patel; Patrycja M Dubielecka; Diana O Treaba; Adam J Olszewski
Journal:  Blood       Date:  2021-02-25       Impact factor: 22.113
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.